Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure
- PMID: 35680380
- DOI: 10.1093/eurheartj/ehac304
Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure
Comment on
-
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.Eur Heart J. 2022 Aug 14;43(31):2984-2993. doi: 10.1093/eurheartj/ehac306. Eur Heart J. 2022. PMID: 35687107 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
